Home › Non-Hodgkinlymfoom › Colorado › Denver
Non-Hodgkinlymfoom klinische studies in Denver, CO
14 studies voor Non-Hodgkinlymfoom zoeken deelnemers op locaties in en rond Denver (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
RekruterenFase 2
- Colorado Blood Cancer Institute ( Site 2726), Denver
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
RekruterenFase 1/2
- Colorado Blood Cancer Institute ( Site 7000), Denver
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RekruterenFase 1
- Colorado Blood Cancer Institute, Denver
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
RekruterenFase 1
- Colorado Blood Cancer Institute, Denver
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
RekruterenFase 1
- Colorado Blood Cancer Institute (Sarah Cannon), Denver
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RekruterenFase 1/2
- Colorado Blood Cancer Institute, Denver
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
RekruterenFase 1/2
- Colorado Blood Cancer Institute, Denver
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
RekruterenFase 3
- Colorado Blood Cancer Institute, Denver
DALY II USA/ MB-CART2019.1 for DLBCL
RekruterenFase 2
- Colorado Blood Cancer Institute, Denver
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekruterenObservatieonderzoek
- Presbyterian St. Luke's/Colorado Blood Cancer Institute, Denver
SynKIR-310 for Relapsed/Refractory B-NHL
RekruterenFase 1
- Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute, Denver
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekruterenObservatieonderzoek
- Kaiser Permanente-Franklin, Denver
- Colorado Blood Cancer Institute, Denver
- Rocky Mountain Cancer Centers-Midtown, Denver
- en nog 1
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Denver
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
RekruterenFase 1
- Colorado Blood Cancer Institute, Denver
Non-Hodgkinlymfoom studies in andere steden
- New York City, NY31 studies
- Houston, TX31 studies
- Boston, MA26 studies
- Nashville, TN21 studies
- Philadelphia, PA20 studies
- Baldwin Park, CA19 studies
- Washington, DC18 studies
- Chicago, IL18 studies
- Atlanta, GA18 studies
- Milwaukee, WI18 studies
- Columbus, OH18 studies
- Dallas, TX17 studies
Andere studies in Denver
- Metastatische kanker29 studies
- Borstkanker29 studies
- Niet-kleincellige longkanker27 studies
- Multipel myeloom27 studies
- Colorectale kanker23 studies
- Melanoom19 studies
- Prostaatkanker19 studies
- Kanker (alle vormen)18 studies
- Eierstokkanker16 studies
- Longkanker16 studies
- Endometriumkanker15 studies
- Aldermeesklierkanker13 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.